Finance

NASDAQ Gainers: Ariad Pharmaceuticals (NASDAQ:ARIA), Yandex NV (NASDAQ:YNDX), GT Advanced Technologies (NASDAQ:GTAT), Oculus Innovative Sciences (NASDAQ:OCLS)

Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) reported financial results for the fourth quarter and full year ended December 31, 2013 and provided an update on corporate developments. Net loss for the fourth quarter ended December 31, 2013 was $74.2 million, or $0.40 per share, compared to a net loss of $60.5 million, or $0.36 per share, for the same period in 2012. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stock performance was 5.56% in last session and finished the day at $8.35. Traded volume was 13,585,193 million shares in the last session and the average volume of the stock remained 27.08 million shares. The beta of the stock remained 1.50. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) insider ownership is 1.70%.

Yandex NV (NASDAQ:YNDX), a Russian internet company, announced today that it acquired KitLocate, an Israeli-based startup that develops energy-efficient geo-location technology for mobile devices.Yandex NV (NASDAQ:YNDX) rose 6.73 percent to $32.03 yesterday on volume of 10.05 million shares. The intra-day range of the stock was $ 31.12 to $ 32.83. Yandex NV (NASDAQ:YNDX) has a market capitalization of $11.15 billion.

GT Advanced Technologies Inc. (NASDAQ:GTAT) charged out of the gate this morning to hit an all-time high of $18.51. Last night, company CEO Tom Gutierrez appeared on CNBC to outline his company’s partnership with Apple Inc. (NASDAQ:AAPL), and investors have responded favorably to this publicity. GT Advanced Technologies Inc (NASDAQ:GTAT)’s stock on Mar18, 2014 reported an increase of 6.36% to the closing price of $18.24. Its fifty two weeks range is $2.63 -$18.51. The total market capitalization recorded $2.45 billion. The overall volume in the last trading session was 15,457,822 million shares. In its share capital, GT Advanced Technologies Inc (NASDAQ:GTAT) has 126.05 million outstanding shares.

Oculus Innovative Sciences, Inc. (Nasdaq:OCLS) could be continuing higher following a positive blog post made Monday afternoon. On Tuesday, shares of Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) advanced 18.70% to close the day at $5.84. Company return on investment (ROI) is -54.10% and its monthly performance is recorded as 89.00%. Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) quarterly revenue growth is 49.74%.